What is the Survivability of Colorectal Cancer in Florida?

The survivability of colorectal cancer in Florida depends largely on the stage at which the cancer is diagnosed, the patient’s age, and access to timely and effective treatment. Colorectal cancer, which includes cancers of the colon and rectum, has a notably higher survival rate when detected early, before it spreads beyond the localized area.

For colorectal cancer confined to the colon or rectum without spread to lymph nodes or distant organs—referred to as localized cancer—the five-year survival rate is quite high. For people under 50, this rate is about 95%, and for those aged 50 and older, it is approximately 90.5%. The ten-year survival rates remain strong as well, with 91.4% for younger patients and 85.3% for older adults. This reflects the effectiveness of early detection and treatment in significantly improving outcomes.

However, when colorectal cancer spreads to regional lymph nodes or distant organs, the survival rates drop considerably. For distant-stage colorectal cancer, where the disease has metastasized to other parts of the body, the five-year survival rate is around 13%. This stark contrast highlights the critical importance of early screening and diagnosis.

In Florida, efforts to improve colorectal cancer survivability focus heavily on increasing screening rates. Screening methods such as colonoscopy and non-invasive tests like Cologuard have been instrumental in detecting cancer early. Programs aimed at closing gaps in preventive healthcare have shown success in raising screening rates, particularly among adults aged 45 to 65. For example, screening rates increased by over 7% in the 45-55 age group and by over 4% in the 56-65 age group in Florida, which is expected to contribute to earlier detection and better survival outcomes.

The incidence of colorectal cancer in Florida varies by county but remains a significant health concern statewide. Urban counties such as Miami-Dade, Palm Beach, Broward, and Orange report high incidence rates, though some have seen stable or slightly declining trends. These regional differences underscore the need for targeted public health strategies to address disparities in cancer detection and treatment access.

Overall, the survivability of colorectal cancer in Florida mirrors national patterns: early-stage detection leads to high survival rates, while late-stage diagnosis results in much poorer outcomes. The state’s focus on improving screening accessibility and patient education is crucial for increasing the number of cancers caught early, thereby enhancing survivability. The availability of convenient, non-invasive screening options and public health initiatives to encourage timely testing are key factors in improving colorectal cancer survival rates in Florida.